Contrasting ZimVie (NASDAQ:ZIMV) & Straumann (OTCMKTS:SAUHY)

ZimVie (NASDAQ:ZIMV – Get Free Report) and Straumann (OTCMKTS:SAUHY – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings. Risk & Volatility ZimVie has a beta of 2.31, indicating […]

Leave a Reply

Your email address will not be published.

Previous post Chicago White Sox announce 4 international signings, including highly touted third baseman Eduardo Herrera
Next post NovoCure Limited (NASDAQ:NVCR) Forecasted to Earn Q1 2024 Earnings of ($0.36) Per Share